ARVIND REMEDIES LIMITED
	REVIEWED FINANCIAL RESULTS
	FOR THE QUARTER ENDED JUNE 30, 2006
				(Rupees in Lakhs.)
	Particulars	Three months ended 30.06.2006	Three months ended 30.06.2005	Year ended 31.3.2006
		Unaudited	Unaudited	Audited
	Gross Sales	4,391.95	4,758.81	16,507.79
	Less: Excise Duty	(474.08)	(576.06)	(2,117.19)
	Net Sales	3,917.87	4,182.75	14,390.60
	Other Income	2.78	0.58	66.10
	Total Income	3,920.65	4,183.33	14,456.70
	Total expenditure :
	a)  (Increase) / Decrease in Stock	153.39	79.75	423.05
	b)  Materials Consumed	3,121.73	3,462.71	12,012.64
	c)  Staff Cost	78.26	68.94	293.97
	d)  Other expenditure	112.56	118.99	597.78
	Total (a) to (d)	3,465.94	3,730.39	13,327.44
	Gross Profit before Interest & Depreciation	454.71	452.94	1,129.26
	Interest	134.25	131.94	476.20
	Depreciation	41.21	38.42	151.25
	Profit before Tax	279.25	282.58	501.81
	Provision for Taxation
	Income Tax (Including Fringe Benefit Tax)	20.00	25.00	92.00
	Earlier years	-	-	18.57
	Deferred Tax	(10.03)	(6.31)	84.13
	Wealth Tax	-	-	0.26
	Profit / (Loss) after Tax	269.28	263.89	306.85
	Paid-up Equity Share Capital	2600.50	2600.50	2600.50
	(face value Re. 1/- per Share)
	Reserves excluding Revaluation Reserve	-	-	1,234.95
	Basic and Diluted Earnings Per Share (Rs.)	0.10	0.10	0.12
	Aggregate of Non-Promoter Shareholding
	Number of shares	194205340	194543405	194205340
	Percentage of Shareholding	74.68%	74.81%	74.68%
	Note :
	1. The Company operates only in one business segment namely  formulations.
	2. Previous period's figures have been regrouped / rearranged  wherever necessary to confirm to the current periods classification.
	3. The above results were taken on record at the meeting of the Board of Directors held on August 29, 2006.
	4. During the quarter 11 investor complaints were received and disposed off.  There were no investor complaints pending for the
	redressal as at the commencement and end of the quarter.
	5. The above results for the quarter ended June 30, 2006, have been subjected to a Limited Review by the statutory auditors as per
	the listing agreement with the stock exchanges.
	Chennai - 600 084		For ARVIND REMEDIES LTD.
	Date: August 29, 2006
			Dr. B Arvind Shah
			CEO and Managing Director
					Back